High Prognostic Value of Mini-Laparoscopy for Advanced Liver Disease-Related Complications in Patients with HCV Infection

被引:3
|
作者
Zizer, Eugen [1 ]
Backhus, Johanna [1 ]
Bohl, Stephan [2 ]
Braun, Anette [1 ]
Baturina, Irina [1 ]
Klass, Dietmar [3 ]
Dikopoulos, Nektarios [1 ]
Seufferlein, Thomas [1 ]
Dollinger, Matthias [1 ]
机构
[1] Univ Ulm, Innere Med Klin 1, Ulm, Germany
[2] Univ Ulm, Innere Med Klin 3, Ulm, Germany
[3] Klin Allgemeine & Innere Med & Gastroenterol, Luneburg, Germany
关键词
HCV; Mini-laparoscopy; Advanced chronic liver disease; Cirrhosis; CHRONIC HEPATITIS-C; SUSTAINED VIROLOGICAL RESPONSE; VENOUS-PRESSURE GRADIENT; PORTAL-HYPERTENSION; CIRRHOSIS; BIOPSY; DIAGNOSIS; PREDICT; RISK;
D O I
10.1159/000449411
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aim: The assessment of advanced chronic liver disease (ACLD) is a prerequisite for therapy and surveillance in patients with chronic hepatitis C infection. Mini-laparoscopy assisted liver biopsies facilitate both histological and macroscopical evaluation of liver fibrosis. This study is aimed at investigating the prognostic significance of the laparoscopic assessment for the cumulative incidence of ACLD-related events. Patients and Methods: We performed a single center, retrospective analysis of 94 patients with either macroscopically or/and microscopically assessed advanced fibrosis/cirrhosis caused by chronic hepatitis C infection. The patients' data, the respective laboratory results, and follow-up period were evaluated in the outpatient clinic. Results: The group with both macro- and microscopic diagnosed ACLD showed a significantly higher number of decompensating events (n = 7) compared with the other 2 groups (n = 0 in the group with only histological and n = 1 in the group with only laparoscopic diagnosis of advanced liver disease). The results were not affected by the successful treatment of the hepatitis C virus. In the Cox-regression analysis, the spleen size (>120 mm) was significantly associated with the incidence of ACLD-related events. Conclusions: Assessment of ACLD in chronic hepatitis C by mini-laparoscopy-assisted liver biopsies may facilitate the selection of patients with a poor prognosis, irrespective of achieving a sustained virological response following treatment. Follow-up of these patients should be intensified to treat decompensation early. (C) 2016 S. Karger AG, Basel
引用
收藏
页码:114 / 122
页数:9
相关论文
共 50 条
  • [1] Liver assessment and biopsy in patients with marked coagulopathy: Value of mini-laparoscopy and control of bleeding
    Denzer, U
    Helmreich-Becker, I
    Galle, PR
    Lohse, AW
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (04): : 893 - 900
  • [2] An independent validation of the mortality score for the short-term prognostic prediction in patients with chronic HCV infection and advanced liver disease
    Giannini, Edoardo G.
    Savarino, Vincenzo
    GUT, 2016, 65 (01) : 183 - +
  • [3] The impact of disease-related knowledge on perceptions of stigma among patients with Hepatitis C Virus (HCV) infection
    Saine, M. Elle
    Szymczak, Julia E.
    Moore, Tyler M.
    Bamford, Laura P.
    Barg, Frances K.
    Forde, Kimberly A.
    Schnittker, Jason
    Holmes, John H.
    Mitra, Nandita
    Lo Re, Vincent, III
    PLOS ONE, 2021, 16 (10):
  • [4] Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
    Charlton, Michael
    Everson, Gregory T.
    Flamm, Steven L.
    Kumar, Princy
    Landis, Charles
    Brown, Robert S., Jr.
    Fried, Michael W.
    Terrault, Norah A.
    O'Leary, Jacqueline G.
    Vargas, Hugo E.
    Kuo, Alexander
    Schiff, Eugene
    Sulkowski, Mark S.
    Gilroy, Richard
    Watt, Kymberly D.
    Brown, Kimberly
    Kwo, Paul
    Pungpapong, Surakit
    Korenblat, Kevin M.
    Muir, Andrew J.
    Teperman, Lewis
    Fontana, Robert J.
    Denning, Jill
    Arterburn, Sarah
    Dvory-Sobol, Hadas
    Brandt-Sarif, Theo
    Pang, Phillip S.
    McHutchison, John G.
    Reddy, K. Rajender
    Afdhal, Nezam
    GASTROENTEROLOGY, 2015, 149 (03) : 649 - 659
  • [5] EFFECT OF RITUXIMAB ON ADVANCED LIVER DISEASE IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA
    Petrarca, Antonio
    Rigacci, Luigi
    Arena, Umberto
    Vizzutti, Francesco
    Giannini, Carlo
    Montalto, Paolo
    Bosi, Alberto
    Colagrande, Stefano
    Romagnoli, Paolo
    Laffi, Giacomo
    Zignego, Anna Linda
    HEPATOLOGY, 2008, 48 (04) : 317A - 318A
  • [6] HIV patients remain at high risk for advanced liver fibrosis after curing HCV infection
    Bolokadze, N.
    Asatiani, M.
    Sharvadze, L.
    Gabunia, P.
    Abutidze, A.
    Chokoshvili, O.
    Gedenidze, N.
    Tsertsvadze, T.
    Chkhartishvili, N.
    HIV MEDICINE, 2019, 20 : 293 - 293
  • [7] Higher frequency of occult HCV infection in HIV/HCV coinfected patients with advanced liver disease: Post DAAs treatment observation
    Bagaglio, Sabrina
    Messina, Emanuela
    Vercesi, Riccardo
    Morsica, Giulia
    Salpietro, Stefania
    Bigoloni, Alba
    Della Torre, Liviana
    Concetta, Vinci
    Lazzarin, Adriano
    Uberti-Foppa, Caterina
    Hasson, Hamid
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E726 - E727
  • [8] Assessment of noninvasive hepatic fibrosis markers among patients with chronic HCV infection and advanced liver disease
    Maan, Raoel
    van der Meer, Adriaan J.
    Feld, Jordan J.
    Wedemeyer, Heiner
    DuFour, Jean-Francois J.
    Lammert, Frank
    Duarte-Rojo, Andres
    Manns, Michael P.
    Zeuzem, Stefan
    Hofmann, Wolf P.
    Janssen, Harry L.
    Hansen, Bettina E.
    Veldt, Bart J.
    de Knegt, Robert J.
    HEPATOLOGY, 2014, 60 : 929A - 930A
  • [9] Utility and prognostic value of diagnosing MAFLD in patients undergoing liver transplantation for alcohol-related liver disease
    Vanlerberghe, Benedict T. K.
    van Malenstein, Hannah
    Sainz-Bariga, Mauricio
    Jochmans, Ina
    Cassiman, David
    Monbaliu, Diethard
    van der Merwe, Schalk
    Pirenne, Jacques
    Nevens, Frederik
    Verbeek, Jef
    CLINICAL TRANSPLANTATION, 2023, 37 (06)
  • [10] Applicability and prognostic value of frailty assessment tools among hospitalized patients with advanced chronic liver disease
    Skladany, Lubomir
    Drotarova, Zuzana
    Vnencakova, Janka
    Jancekova, Daniela
    Molcan, Pavol
    Koller, Tomas
    CROATIAN MEDICAL JOURNAL, 2021, 62 (01) : 8 - 16